Company intelligence / Profile preview

Axio Labs

Ahmedabad, Gujarat, India

Ownership: Private
Employees: ~150
Development stage: Other

Overview

Axio Biosolutions is a deep-science medtech company that develops advanced surgical and wound care products using novel biomaterials. Its flagship product, Axiostat, is a high-performance hemostatic dressing used by military, emergency services, and hospitals to control life-threatening bleeding. The company also develops Maxio, a next-generation wound care solution for chronic and post-surgical wounds. Headquartered in Boston with R&D in India, Axio focuses on leveraging chitosan-based technology to address unmet needs in trauma and surgical care.

Therapeutic areas: HematologyDermatology
Modalities: BiomaterialsChitosan-based polymers
Industry: Consumable Medical Devices

Beyond the preview

Go deeper on Axio Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Axio Labs.

Explore the full profile